Senior Institutional Account Manager
Current*Develop and execute strategic business plans for novel rare disease cardiovascular medication, CAMZYOS, the first approved cardiac myosin inhibitor for the treatment of obstructive hypertrophic cardiomyopathy (HCM).*Collaborate with numerous Matrix Partners including Reimbursement, REMS Advisors, Community Territory Managers, and multiple levels of customers to ensure access to CAMZYOS. *Winners Circle 2023, #1 in Mid-Atlantic Region and #2 in nation.